Semaglutide Dosing and Administration Guidelines

Dosing Guidelines

• The American Diabetes Association recommends a maximum dose of 2.0 mg once weekly for type 2 diabetes glycemic control, following a structured dose escalation protocol 1, 2
• For chronic weight management in adults with BMI ≥30 kg/m² or BMI ≥27 kg/m² with at least one weight-related comorbidity, the maximum approved dose is 2.4 mg once weekly, with the same initial titration schedule as the diabetes indication 2, 3

Efficacy and Safety

• Semaglutide 2.4 mg results in approximately 9.6% total body weight loss compared to 3.4% with placebo, for weight management 4
• No dosage adjustments are required for patients with renal impairment, according to the Mayo Clinic Proceedings 5, 1
• The American College of Cardiology notes that semaglutide is contraindicated in pregnancy, personal/family history of medullary thyroid cancer, and multiple endocrine neoplasia syndrome type 2 7

Administration and Monitoring

• The American Diabetes Association recommends administering semaglutide once weekly at any time of day, with or without meals, and injecting subcutaneously in the abdomen, thigh, or upper arm 1, 5
• Monitor for potential risks including pancreatitis, gallbladder disease, and hypoglycemia (especially when used with insulin or sulfonylureas) 4, 7